Immune checkpoint-regulatable hydrogel-immobilized nanotherapeutics for post-surgical treatment of osteosarcoma

骨肉瘤 免疫系统 免疫检查点 化学 癌症研究 医学 免疫疗法 免疫学
作者
Da‐Wang Zhao,Zhiliang Gao,Meng Si,Rui Hu,Xue Ma,Kaiwen Liu,Yixiang Zhao,Qiting He,Xiangzhen Kong,Chunwang Jia,Haoxin Zhai,Yuanqiang Zhang,Lei Cheng,Jiwei Cui,Hecheng Ma
出处
期刊:Chemical Engineering Journal [Elsevier]
卷期号:498: 155072-155072 被引量:1
标识
DOI:10.1016/j.cej.2024.155072
摘要

• Chemo-immunotherapy could revolutionize the treatment of osteosarcoma. • Gel-immobilized nanotherapeutics mitigate osteosarcoma recurrence and propagation. • The STING agonists result in the initiation of T cell-mediated immune responses. Osteosarcoma recurrence following surgical resection is notoriously prevalent and resistant to chemotherapy ( i.e. , doxorubicin, DOX) due to its intricate immunosuppressive tumor microenvironment, which remains one of the most life-threatening tumors. In this study, we report the fabrication of an in-situ injectable hydrogel-immobilized nanotherapeutics, tailored to stimulate tumoricidal immunity, thus mitigate both localized osteosarcoma recurrence and the propagation of metastatic tumors subsequent to surgical intervention. Zeolitic imidazolate framework-8 nanoparticles (ZIF NPs), encapsulating a chemotherapeutic agent ( i.e. , DOX) and immunotherapeutic agents ( i.e. , αPDL1 and αCD47), are loaded in fibrin hydrogels. These bioengineered constructs are judiciously deployed at surgical sites to orchestrate chemo-immunotherapeutic interventions, effectuated through the controlled release of doxorubicin and the initiation of T cell-mediated immune responses. DOX has the capability to eradicate tumor cells and initiate immunogenic cell death. Notably, αPDL1 engenders the circumvention of PDL1-mediated resistance and dominates metastatic tumor expansion, thereby exerting a pivotal role in the context of systemic immunosuppression. αCD47 blocks the 'don't eat me' signaling axis intrinsic to cancer cells, thereby potentiating their phagocytosis by macrophages. This orchestrated blockade synergistically activates the host immune milieu, thereby repressing tumor recurrence and curtailing the growth of metastatic lesions post-surgical resection in the subcutaneous tumor model (lateral and bilateral) and tibial tumor model (orthotopic and metastatic), respectively. Additionally, zinc ions from the degradation of ZIF NPs acts as the stimulator of interferon genes (STING) agonists to enhance the immunotherapeutic activity against distal and metastatic tumors. The reported immune checkpoint-regulatable cancer immunotherapy activates the host innate and adaptive immune systems, which shows promising for the treatment of osteosarcoma patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
奋斗的杰完成签到,获得积分10
1秒前
15327432191完成签到 ,获得积分10
1秒前
1秒前
喜洋洋发布了新的文献求助10
3秒前
胖达发布了新的文献求助10
3秒前
4秒前
Harper发布了新的文献求助30
4秒前
5秒前
丘比特应助明亮的泥猴桃采纳,获得10
6秒前
斯文完成签到,获得积分20
6秒前
lin发布了新的文献求助10
7秒前
7秒前
小马甲应助sokach采纳,获得10
7秒前
zz完成签到 ,获得积分10
8秒前
lalala发布了新的文献求助10
8秒前
yin应助胖达采纳,获得10
8秒前
科研通AI2S应助han采纳,获得10
9秒前
9秒前
林谷雨完成签到 ,获得积分10
10秒前
Darker完成签到,获得积分10
11秒前
酷波er应助清新的麦片采纳,获得10
11秒前
斯文发布了新的文献求助10
11秒前
12秒前
LXL完成签到,获得积分10
13秒前
14秒前
14秒前
coconut完成签到 ,获得积分10
14秒前
费小曼完成签到,获得积分10
14秒前
qqs发布了新的文献求助10
15秒前
XIN发布了新的文献求助10
16秒前
16秒前
爱学习的辣妹完成签到,获得积分10
17秒前
大个应助胖胖采纳,获得10
17秒前
小野发布了新的文献求助10
17秒前
轻松的天真完成签到,获得积分10
18秒前
米米完成签到 ,获得积分10
18秒前
李健应助小张采纳,获得10
18秒前
李爱国应助Nn采纳,获得10
19秒前
20秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Mechanistic Modeling of Gas-Liquid Two-Phase Flow in Pipes 2500
Kelsen’s Legacy: Legal Normativity, International Law and Democracy 1000
Handbook on Inequality and Social Capital 800
Conference Record, IAS Annual Meeting 1977 610
Interest Rate Modeling. Volume 3: Products and Risk Management 600
Interest Rate Modeling. Volume 2: Term Structure Models 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3546508
求助须知:如何正确求助?哪些是违规求助? 3123622
关于积分的说明 9356111
捐赠科研通 2822292
什么是DOI,文献DOI怎么找? 1551314
邀请新用户注册赠送积分活动 723303
科研通“疑难数据库(出版商)”最低求助积分说明 713699